BRIEF published on 11/07/2024 at 22:15, 1 year 6 months ago GENFIT Reports Third Quarter 2024 Financial Update Revenue Growth PBC Treatment GENFIT Financials Cash Position 2024 Ipsen Collaboration
BRIEF published on 11/07/2024 at 22:15, 1 year 6 months ago GENFIT publie ses résultats financiers du troisième trimestre 2024 Croissance Des Revenus Traitement De La CBP Chiffres Financiers De GENFIT Situation De Trésorerie 2024 Collaboration Ipsen
PRESS RELEASE published on 11/07/2024 at 22:10, 1 year 6 months ago GENFIT Reports Third Quarter 2024 Financial Information GENFIT reports €59.7M revenue for Q3 2024 with €96.0M cash. Focus on liver diseases. Results surpass 2023 Revenue Cash Position Q3 2024 Liver Diseases GENFIT
PRESS RELEASE published on 09/19/2024 at 22:10, 1 year 7 months ago GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
PRESS RELEASE published on 09/19/2024 at 22:10, 1 year 7 months ago GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société
PRESS RELEASE published on 09/19/2024 at 18:52, 1 year 7 months ago Rapport d'activité et financier semestriel 2024 - Rapport des Commissaires aux Comptes
PRESS RELEASE published on 09/19/2024 at 18:46, 1 year 7 months ago Rapport d'activité et financier semestriel 2024 - Attestation du Responsable
PRESS RELEASE published on 09/19/2024 at 18:40, 1 year 7 months ago Rapport d'activité et financier semestriel 2024
BRIEF published on 07/26/2024 at 13:50, 1 year 9 months ago GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® in Primary Biliary Cholangitis GENFIT EMA Iqirvo® Elafibranor PBC Treatment
BRIEF published on 07/26/2024 at 13:50, 1 year 9 months ago GENFIT : Avis positif du comité de l'EMA pour Iqirvo® d'Ipsen dans la cholangite biliaire primitive GENFIT EMA Iqirvo® Elafibranor Traitement De La CBP
Published on 05/08/2026 at 01:50, 5 hours 40 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 6 hours 45 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 7 hours 30 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 8 hours ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 8 hours 15 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/08/2026 at 06:45, 45 minutes ago Krones starts financial year with strong order intake and confirms financial targets for 2026
Published on 05/08/2026 at 06:40, 49 minutes ago Jungfraubahn Holding AG: Jungfrau Railway Group: After a subdued start to 2026, this trend is becoming more pronounced
Published on 05/08/2026 at 06:30, 1 hour ago Interroll Holding AG announces the acquisition of Royal Apollo Group
Published on 05/08/2026 at 06:30, 1 hour ago Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026
Published on 05/07/2026 at 19:15, 12 hours 15 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 12 hours 15 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 12 hours 24 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 12 hours 24 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 12 hours 30 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
